Tièche, C. C., Peng, R., Dorn, P., Froment, L., Schmid, R. A., & Marti, T. M. (2016). Prolonged pemetrexed pretreatment augments persistence of cisplatin-induced DNA damage and eliminates resistant lung cancer stem-like cells associated with EMT. BMC Cancer.
Chicago Style CitationTièche, Colin Charles, Ren-Wang Peng, Patrick Dorn, Laurène Froment, Ralph Alexander Schmid, i Thomas Michael Marti. "Prolonged Pemetrexed Pretreatment Augments Persistence of Cisplatin-induced DNA Damage and Eliminates Resistant Lung Cancer Stem-like Cells Associated With EMT." BMC Cancer 2016.
Cita MLATièche, Colin Charles, et al. "Prolonged Pemetrexed Pretreatment Augments Persistence of Cisplatin-induced DNA Damage and Eliminates Resistant Lung Cancer Stem-like Cells Associated With EMT." BMC Cancer 2016.